Severe hyperglucagonaemia during treatment with oxymetholone.

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Hyperglucagonaemia and treatment with danazol for systemic lupus erythematosus.

The patient's temperature fell to 36'C in the first 20 hours but then fluctuated up to 38'C for five days. Further doses of quinine every 12 hours (maximum 12-2 mg/kg daily) steadily reduced the parasitaemia to zero in six days. The therapeutic concentration of plasma quinine ranged between 10-3 and 25-6 mmol/l (3 and 8 isg/ml). Six doses were given intravenously (two were only 250 mg), then 14...

متن کامل

Oxymetholone treatment for sickle cell anemia.

Seven patients with sickle cell anemia were treated with oxymetholone for at least 2 mo. Markedly increased basal rates of hemolysis and erythropoiesis were confirmed. The urinary erythropoietin excretion was either normal or lower than expected for the red cell mass, and an expanded blood volume was due primarily to an increased plasma volume. After androgen therapy, six patients demonstrated ...

متن کامل

Severe Hypo- -Lipoproteinemia During Treatment With Rosiglitazone

Thiazolidinedione drugs are in widespread use for the treatment of type 2 diabetes. In addition to improving insulin sensitivity, they generally result in a modest elevation of plasma HDL cholesterol. We report three patients, all of whom had preexisting diabetic dyslipidemia, who showed a profound reduction in plasma HDL cholesterol and apolipoprotein AI levels soon after the initiation of ros...

متن کامل

Oxymetholone treatment for the anemia of bone marrow failure.

Oxymetholone was given to 28 adults with chronic anemia from bone marrow disease. Changes in hematocrit and red cell mass were correlated with serial assessments of erythropoietin and erythropoiesis. Erythropoietin excretion was enhanced more than fivefold over the level expected for the hematocrit in 70#{176}/o of the patients. Only 23#{176}/o of the patients with an evaluable treatment trial ...

متن کامل

Treatment of severe axillary Hyperhidrosis with Botulinum toxin A

Background: Severe axillary hyperhidrosis causes considerable emotional stress to individuals affected with this condition. Existing topical and surgical therapies are either ineffective or associated with unacceptable morbidity and sequelae. Objective: In this study we attempted to determine the effect of botulinum toxin A (Dysport) in the treatment of axillary hyperhidrosis. Patients and Meth...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: BMJ

سال: 1986

ISSN: 0959-8138,1468-5833

DOI: 10.1136/bmj.292.6536.1637